Operating Income (Loss) of Core Laboratories Inc. /DE/ from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Core Laboratories Inc. /DE/ quarterly and annual Operating Income (Loss) in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • Core Laboratories Inc. /DE/ Operating Income (Loss) for the quarter ending 30 Sep 2025 was $20,928,000, a 5.7% increase year-over-year.
  • Core Laboratories Inc. /DE/ Operating Income (Loss) for the twelve months ending 30 Sep 2025 was $54,810,000, a 7% decline year-over-year.
  • Core Laboratories Inc. /DE/ annual Operating Income (Loss) for 2024 was $58,556,000, a 7.2% increase from 2023.
  • Core Laboratories Inc. /DE/ annual Operating Income (Loss) for 2023 was $54,640,000, a 32% increase from 2022.
  • Core Laboratories Inc. /DE/ annual Operating Income (Loss) for 2022 was $41,524,000, a 8.3% decline from 2021.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Core Laboratories Inc. /DE/ Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $54,810,000 $20,928,000 +$1,125,000 +5.7% 01 Jul 2025 30 Sep 2025 10-Q 23 Oct 2025 2025 Q3
Q2 2025 $53,685,000 $15,291,000 -$717,000 -4.5% 01 Apr 2025 30 Jun 2025 10-Q 25 Jul 2025 2025 Q2
Q1 2025 $54,402,000 $4,417,000 -$4,154,000 -48% 01 Jan 2025 31 Mar 2025 10-Q 28 Apr 2025 2025 Q1
Q4 2024 $58,556,000 $14,174,000 -$407,000 -2.8% 01 Oct 2024 31 Dec 2024 10-K 13 Feb 2025 2024 FY
Q3 2024 $58,963,000 $19,803,000 +$5,131,000 +35% 01 Jul 2024 30 Sep 2024 10-Q 23 Oct 2025 2025 Q3
Q2 2024 $53,832,000 $16,008,000 -$2,898,000 -15% 01 Apr 2024 30 Jun 2024 10-Q 25 Jul 2025 2025 Q2
Q1 2024 $56,730,000 $8,571,000 +$2,090,000 +32% 01 Jan 2024 31 Mar 2024 10-Q 28 Apr 2025 2025 Q1
Q4 2023 $54,640,000 $14,581,000 01 Oct 2023 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q3 2023 $14,672,000 +$27,000 +0.18% 01 Jul 2023 30 Sep 2023 10-Q 24 Oct 2024 2024 Q3
Q2 2023 $18,906,000 +$7,254,000 +62% 01 Apr 2023 30 Jun 2023 10-Q 25 Jul 2024 2024 Q2
Q1 2023 $6,481,000 01 Jan 2023 31 Mar 2023 10-Q 25 Apr 2024 2024 Q1
Q3 2022 $14,645,000 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $11,652,000 01 Apr 2022 30 Jun 2022 10-Q 27 Jul 2023 2023 Q2

Core Laboratories Inc. /DE/ Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $58,556,000 +$3,916,000 +7.2% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2025 2024 FY
2023 $54,640,000 +$13,116,000 +32% 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2025 2024 FY
2022 $41,524,000 -$3,738,000 -8.3% 01 Jan 2022 31 Dec 2022 10-K 13 Feb 2025 2024 FY
2021 $45,262,000 01 Jan 2021 31 Dec 2021 10-K 15 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.